Abstract:Medical students are likely to be exposed to COVID‐19 patients so achieving high vaccination coverage rates for this group of healthcare workers is important, as is their potential as vaccination role models. The aim of this scoping review was to evaluate the current literature to determine the rates of COVID-19 vaccine hesitancy and acceptance, and associated factors, amongst medical students. Systematic searches of the Medline Ovid, Embase, PubMed, and Education Resources Information Centre (ERIC) online dat… Show more
“…Among these articles, a prevailing theme emerged regarding the dynamics of vaccine acceptance versus hesitancy. A notable majority, comprising 51 articles, indicated that the willingness to receive vaccination outweighed hesitancy [5,6]. The vaccine hesitancy appeared to be more pronounced during the initial stages of the pandemic when COVID-19 was still considered novel.…”
Vaccination remains a cornerstone of public health, yet persistent pockets of vaccine hesitancy challenge its widespread acceptance. This review explores the intricate interplay between the COVID-19 pandemic and vaccine hesitancy, examining how the introduction of the COVID-19 vaccine has influenced broader attitudes towards vaccination. A systematic review of literature spanning 2021 to 2023 elucidates the multifaceted factors influencing vaccine acceptance and hesitancy, including socio-demographic disparities, misinformation, and healthcare access.Findings reveal a nuanced landscape, where sociodemographic variables significantly impact vaccine acceptance, while misinformation from media sources exacerbates hesitancy. Promising interventions, such as immersive virtual reality experiences, financial incentives, and political endorsements, offer avenues to mitigate hesitancy and enhance vaccine uptake. Furthermore, the pivotal role of healthcare professionals in promoting vaccination and combatting misinformation underscores the importance of leveraging trust and expertise to shape public perceptions. Employer recommendations and tailored educational initiatives emerge as practical strategies to encourage vaccine acceptance within communities. This review underscores the imperative for targeted interventions grounded in evidence-based practices to address vaccine hesitancy effectively and safeguard public health in the face of evolving challenges.
“…Among these articles, a prevailing theme emerged regarding the dynamics of vaccine acceptance versus hesitancy. A notable majority, comprising 51 articles, indicated that the willingness to receive vaccination outweighed hesitancy [5,6]. The vaccine hesitancy appeared to be more pronounced during the initial stages of the pandemic when COVID-19 was still considered novel.…”
Vaccination remains a cornerstone of public health, yet persistent pockets of vaccine hesitancy challenge its widespread acceptance. This review explores the intricate interplay between the COVID-19 pandemic and vaccine hesitancy, examining how the introduction of the COVID-19 vaccine has influenced broader attitudes towards vaccination. A systematic review of literature spanning 2021 to 2023 elucidates the multifaceted factors influencing vaccine acceptance and hesitancy, including socio-demographic disparities, misinformation, and healthcare access.Findings reveal a nuanced landscape, where sociodemographic variables significantly impact vaccine acceptance, while misinformation from media sources exacerbates hesitancy. Promising interventions, such as immersive virtual reality experiences, financial incentives, and political endorsements, offer avenues to mitigate hesitancy and enhance vaccine uptake. Furthermore, the pivotal role of healthcare professionals in promoting vaccination and combatting misinformation underscores the importance of leveraging trust and expertise to shape public perceptions. Employer recommendations and tailored educational initiatives emerge as practical strategies to encourage vaccine acceptance within communities. This review underscores the imperative for targeted interventions grounded in evidence-based practices to address vaccine hesitancy effectively and safeguard public health in the face of evolving challenges.
“…In other words, COVID-19 vaccination did not appear to have a significant effect on HA levels. Given the impact of vaccination on the immune response and the development of novel vaccine technologies, it is necessary to further evaluate their potential role in HA production and other important physiological processes (Pandher and Bilszta, 2023).…”
ObjectivePrevious research has shown that human identical sequences of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) promote coronavirus disease 2019 (COVID-19) progression by upregulating hyaluronic acid (HA). However, the association of HA with mortality and long COVID in SARS-CoV-2 reinfection and first infection is unclear.MethodsPatients with COVID-19 at Beijing Ditan Hospital from September 2023 to November 2023 were consecutively enrolled. SARS-CoV-2 reinfections were matched 1:2 with first infections using a nearest neighbor propensity score matching algorithm. We compared the hospital outcomes between patients with COVID-19 reinfection and first infection. The association between HA levels and mortality and long COVID in the matched cohort was analyzed.ResultsThe reinfection rate among COVID-19 hospitalized patients was 25.4% (62 cases). After propensity score matching, we found that reinfection was associated with a better clinical course and prognosis, including lower levels of C-reactive protein and erythrocyte sedimentation rate, fewer cases of bilateral lung infiltration and respiratory failure, and shorter viral clearance time and duration of symptoms (p < 0.05). HA levels were significantly higher in patients with primary infection [128.0 (90.5, 185.0) vs. 94.5 (62.0, 167.3), p = 0.008], those with prolonged viral clearance time [90.5 (61.5, 130.8) vs. 130.0 (95.0, 188.0), p < 0.001], and deceased patients [105.5 (76.8, 164.5) vs. 188.0 (118.0, 208.0), p = 0.002]. Further analysis showed that HA was an independent predictor of death (AUC: 0.789), and the risk of death increased by 4.435 times (OR = 5.435, 95% CI = 1.205–24.510, p = 0.028) in patients with high HA levels. We found that patients with HA levels above 116 ng/mL had an increased risk of death. However, the incidence of long COVID was similar in the different HA level groups (p > 0.05).ConclusionSerum HA may serve as a novel biomarker for predicting COVID-19 mortality in patients with SARS-CoV-2 reinfection and first infection. However, HA levels may not be associated with long COVID.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.